Supplementation with carotenoids, omega-3 fatty acids, and vitamin E has a positive effect on the symptoms and progression of Alzheimer's disease

Manuscript Number: 

22-0556R2

Author(s): 
Paula Bergin, John Cooke, Alan N. Howard, Riona Mulcahy, John M. Nolan, George Pope, Rebecca Power, Tommy Power, Alfonso Prado-Cabrero, Warren Roche

Disclosures

Paula Bergin

  • Nothing to Disclose

John Cooke

  • Grants
    • Agency: 
      GlanBia Ireland
      Dates: 
      01/06/2018 - Current

Alan N. Howard

  • Nothing to Disclose

Riona Mulcahy

  • Nothing to Disclose

John M. Nolan

  • Consulting Fees:
    As a director of NOW-Science Consultancy Ltd, the company receives consulting fees for providing consultancy advice and educational lectures. Also, I sit on an advisory board for Heidelberg Engineering Ltd for which the company is paid.
    Patents/Royalties
    I am an inventor on several published patents in the area of carotenoid formulations but I do not own the IP from these patents, which is managed by my university at the South East Technological University.

George Pope

  • Nothing to Disclose

Rebecca Power

  • Consulting Fees:
    RP has previously performed consultancy work for MacuHealth LLCTM (Birmingham, MI, USA). This organization has an interest in commercially available supplements containing the macular carotenoids.
    Sponsors:
    For the Re-MIND trial, RP was funded in part by the Howard Foundation (registered with the Charity Commission of England & Wales #285822). This organization has an interest in commercially available supplements containing the macular carotenoids.

Tommy Power

  • Nothing to Disclose

Alfonso Prado-Cabrero

  • Equity:
    Shares in Supplement Certified Ltd, dedicated to analyse commercial dietary supplements containing the macular carotenoids and omega-3 fatty acids, intended for improving human vision and cognition.

Warren Roche

  • Nothing to Disclose